MCLEAN, Va.--(BUSINESS WIRE)--Capital One Software, the enterprise B2B software business of Capital One, today announced intelligent optimization features for Capital One Slingshot, designed to ...

When Microsoft Clarity made AI citations available to all users, it opened up a new playground for SEOs to harvest AI visibility data. Finally, we can see the exact “grounding queries” an AI engine ...

The rules of search are changing. And it’s forcing a lot of companies to ask themselves a fundamental question: How do we get noticed now? For two decades, companies have relied on search-engine ...

New AI capabilities help DBAs move from performance visibility to performance resolution—turning slow queries into actionable index recommendations in minutes HOUSTON, March 19, 2026 /PRNewswire/ -- ...

For years, digital discovery followed a familiar pattern. A user Googled their query, scanned from the top-ranked options, then clicked a few links to find what they needed. But increasingly, ...

ABSTRACT: Multi-objective optimization remains a significant and realistic problem in engineering. A trade-off among conflicting objectives subject to equality and inequality constraints is known as ...

Agencies are repackaging old SEO fundamentals as “AI SEO.” Here’s how to spot what’s truly new versus what’s just clever rebranding. Something’s shifting in how SEO services are being marketed, and if ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Joe Cassavaugh shares his journey from ...

This post was sponsored by Writesonic. The opinions expressed in this article are the sponsor’s own. AI search now makes the first decision. When? Before a buyer hits your website. Not you. Your brand ...

Have you ever found yourself staring at a spinning wheel, waiting for your Power Query to refresh, only to wonder if there’s a better way? For anyone working with large datasets, refresh delays aren’t ...

Patritumab Deruxtecan (HER3-DXd; MK-1022) in Non–Small Cell Lung Cancer After Platinum-Based Chemotherapy and Immunotherapy Many drugs in development continue to follow the historical drug development ...